[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Cardiovascular Information System Market Research and Forecast 2017-2022

August 2017 | | ID: G029358EB87EN
Orion Market Research Private Limited

US$ 3,600.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The Global Cardiovascular Information System Market is expected to grow at a CAGR of 11% during 2017-2022. Cardiovascular Information System is an approach that provides access and management of patient’s digital integrated cardiovascular records from a centralized and web-enabled system. Moreover, Cardiovascular Information System enables patient management through an approach of built-in report generation and distribution process and thus increases the speed of reimbursements. According to WHO, in 2015 more than 17.7 million patients lost their life due to CVD which is estimated to be around 30% of global mortalities. The rapid increase in global count of patients suffering from CVDs is the major factor which is driving the cardiovascular information market growth. According to the European Heart Network, in 2015, Europe holds 85 million people having CVD related diseases out of which 49 million is in the EU region. More than 11 million new cases of CVD were added out of which 6 million of EU in 2015. Due to these increased number of disease and disorders, a rising demand for productive and effective data management tools in the cardiac care departments has been generated which is motivating the market. Additionally, the government initiatives towards Electronic Health Records for managing patient’s data digitally is encouraging the healthcare organizations to implement cardiovascular information systems and affecting the market growth in a positive mode. The Health Information Technology for Economic and Clinical Health Act (HITECH Act) legislation passed in 2009 which supports the adoption of electronic health records (EHR) and supporting technology in the U.S.

High costs of cardiovascular Information Systems and lack of skilled personals regarding market tools and techniques are some of the restraints that are hindering the market growth. However, growing innovations and technological advancements in cardiovascular information system the market has been boosted. it is expected more number of secure, cost-effective and robust mechanisms in the upcoming years which can make them available for general uses as well. Additionally, a rising demand of cardiovascular information systems exists in healthcare applications due to the increase in cardiovascular diseases. This increasing demand will enable a high growth of Cardiovascular Information System market in other developing countries and small-sized organizations as well.

Geographical Insights

Global Cardiovascular Information System market can be segmented on the basis of the geographical regions that are known for their significant contribution towards the growth of the market. On the basis of the geography, market is distributed into North America, Europe, Asia Pacific and Rest of the World. North America is estimated to be the dominating region in the Global Cardiovascular information System market due to the more number of adoptions of Cardiovascular Information System by the healthcare industries and surging prevalence of CVDs in the region as well as awareness among the people towards this technological advancement. However, Asia pacific region is expected to achieve the highest growth rate during the forecast period due to the EHR highly incorporated by the governments. They have been highly motivated in developing Asian countries such as China, India and so forth.

Competitive Insights

The Key Players in the Global Cardiovascular Information Market includes Agfa Healthcare N.V., ARCport, Camtronics Medical Systems Ltd., Cerner Corporation, Digisonics, Inc., Ebit Aet, Fujifilm Medical Systems, Inc., GE Healthcare, Johnson & Johnson, McKesson Corporation, Medstreaming, Perminova, Inc., Philips Healthcare, Siemens Healthcare GmbH, , Terumo Cardiovascular Group and so on. The key strategies adopted by these players are new product launch covering a wide range of applications, customer-centric products, acquisition and collaboration. A wide range of products such as IntelliSpace and Xcelera are available by Philips Healthcare.. IntelliSpace Cardiovascular is multi-modality image and information management solution which is designed to improve operational efficiency and help streamline workflow.

Market Segmentation

Global Cardiovascular Information System Market is segmented on the basis of its applications, deployment method used and system type. The applications in diverse clinical diagnosis are generating noticeable revenue due to its use in healthcare industries. Additionally, the website or cloud based Cardiovascular Information Systems are the major contributors in revenue generation due to their high adoption and cost effectiveness compared to on-site based services. Global Cardiovascular Information System market can be segmented in the following three major categories:

Cardiovascular Information System Market By Type

Cardiovascular Information System Market By Applications

Cardiovascular Information System Market By Deployment

The report covers:
  • Comprehensive research methodology of Global Cardiovascular Information System Market. This report also includes detailed and extensive market overview with Analyst insights & key market trends.
  • Exhaustive Analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the Global Cardiovascular Information System Market.
  • Insights about market determinants which are stimulating the Global Cardiovascular Information System Market
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.
REPORT SUMMARY

1.1. RESEARCH METHODS AND TOOLS
1.2. MARKET BREAKDOWN
  1.2.1. BY SEGMENTS
  1.2.2. BY GEOGRAPHY
  1.2.3. BY STAKEHOLDERS

MARKET OVERVIEW AND INSIGHTS

2.1. DEFINITION
2.2. ANALYST INSIGHT & CURRENT MARKET TRENDS
  2.2.1. KEY FINDINGS
  2.2.2. RECOMMENDATION
  2.2.3. CONCLUSION
2.3. REGULATIONS
  2.3.1. UNITED STATES
  2.3.2. EUROPEAN UNION
  2.3.3. CHINA
  2.3.4. INDIA
  2.3.5. REST OF THE WORLD

MARKET DETERMINANT

3.1. MOTIVATORS
  3.1.1. RISING CARDIOVASCULAR DISEASE INCIDENCES
  3.1.2. GOVERNMENT INITIATIVES TOWARDS EHR SYSTEMS
  3.1.3. RISING GERIATRIC POPULATION
  3.1.4. GROWING NEED OF CVIS IN HOSPITALS
  3.1.5. INCREASE IN MEDICATION ERRORS
3.2. RESTRAINTS
  3.2.1. LACK OF STANDARDS HEALTHCARE PROTOCOLS FOR CVIS IMPLEMENTATION
  3.2.2. HIGH COSTS OF CVIS
3.3. OPPORTUNITIES
  3.3.1. TECHNOLOGICAL ADVANCEMENTS
  3.3.2. RISING NEED FOR CVIS IN HOSPITALS
  3.3.3. GROWTH IN SKILLED PERSONALS

MARKET SEGMENTATION

4.1. CARDIOVASCULAR INFORMATION SYSTEM MARKET BY TYPE
  4.1.1. CARDIOVASCULAR INFORMATION SYSTEMS.
  4.1.2. CARDIOVASCULAR PICTURE ARCHIVE AND COMMUNICATIONS SYSTEM.
4.2. CARDIOVASCULAR INFORMATION SYSTEM MARKET BY APPLICATIONS
  4.2.1. HEART FAILURE CENTRE EVIS SOLUTIONS
  4.2.2. ECG AND HOLTER MONITORING EVIS SOLUTIONS
  4.2.3. CATHETERIZATION EVIS SOLUTIONS
  4.2.4. NUCLEAR CARDIOLOGY EVIS SOLUTIONS
  4.2.5. ELECTROPHYSIOLOGY EVIS SOLUTIONS
  4.2.6. CARDIOTHORACIC EVIS SOLUTIONS
  4.2.7. ECHOCARDIOGRAPHY LAB EVIS SOLUTIONS
4.3. CARDIOVASCULAR INFORMATION SYSTEM MARKET BY DEPLOYMENT
  4.3.1. ON-SITE BASED
  4.3.2. CLOUD OR WEBSITE BASED

KEY COMPANY ANALYSIS

  5.1.1. KEY STRATEGIES
  5.1.2. KEY COMPANY ANALYSIS

REGIONAL ANALYSIS

6.1. NORTH AMERICA
  6.1.1. UNITED STATES
  6.1.2. CANADA
  6.1.3. REST OF NORTH AMERICA
6.2. EUROPE
  6.2.1. UNITED KINGDOM
  6.2.2. FRANCE
  6.2.3. GERMANY
  6.2.4. ITALY
  6.2.5. SPAIN
  6.2.6. REST OF EUROPE
6.3. ASIA PACIFIC
  6.3.1. INDIA
  6.3.2. CHINA
  6.3.3. JAPAN
6.4. REST OF THE WORLD

COMPANY PROFILES

7.1. AGFA HEALTHCARE N.V
  7.1.1. INTRODUCTION
  7.1.2. AGFA HEALTHCARE N.V PRODUCT PORTFOLIO
  7.1.3. AGFA HEALTHCARE N.V RECENT ACTIVITIES
7.2. ARCPORT
  7.2.1. INTRODUCTION
  7.2.2. ARCPORTPRODUCT PORTFOLIO
  7.2.3. ARCPORTRECENT ACTIVITIES
7.3. CAMTRONICS MEDICAL SYSTEMS LTD.
  7.3.1. INTRODUCTION
  7.3.2. CAMTRONICS MEDICAL SYSTEMS LTD. PRODUCT PORTFOLIO
  7.3.3. CAMTRONICS MEDICAL SYSTEMS LTD. RECENT ACTIVITIES
7.4. CERNER CORPORATION.
  7.4.1. INTRODUCTION
  7.4.2. CERNER CORPORATION. PRODUCT PORTFOLIO
  7.4.3. CERNER CORPORATION. RECENT ACTIVITIES
7.5. DIGISONICS, INC.
  7.5.1. INTRODUCTION
  7.5.2. DIGISONICS, INC. PRODUCT PORTFOLIO
  7.5.3. DIGISONICS, INC. RECENT ACTIVITIES
7.6. EBIT AET
  7.6.1. INTRODUCTION
  7.6.2. EBIT AET PRODUCT PORTFOLIO
  7.6.3. EBIT AET BIOSYSTEMS RECENT ACTIVITIES
7.7. EPIC SYSTEMS CORPORATION
  7.7.1. INTRODUCTION
  7.7.2. EPIC SYSTEMS CORPORATION PRODUCT PORTFOLIO
  7.7.3. EPIC SYSTEMS CORPORATION RECENT ACTIVITIES
7.8. FUJIFILM MEDICAL SYSTEMS, INC.
  7.8.1. INTRODUCTION
  7.8.2. FUJIFILM MEDICAL SYSTEMS, INC. PRODUCT PORTFOLIO
  7.8.3. FUJIFILM MEDICAL SYSTEMS, INC. RECENT ACTIVITIES
7.9. GE HEALTHCARE
  7.9.1. INTRODUCTION
  7.9.2. GE HEALTHCARE PRODUCT PORTFOLIO
  7.9.3. GE HEALTHCARE RECENT ACTIVITIES
7.10. INFINITT NORTH AMERICA INC.
  7.10.1. INTRODUCTION
  7.10.2. INFINITT NORTH AMERICA INC. PRODUCT PORTFOLIO
  7.10.3. INFINITT NORTH AMERICA INC. RECENT ACTIVITIES
7.11. JOHNSON & JOHNSON
  7.11.1. INTRODUCTION
  7.11.2. JOHNSON & JOHNSON PRODUCT PORTFOLIO
  7.11.3. JOHNSON & JOHNSON RECENT ACTIVITIES
7.12. LUMEDX CORPORATION
  7.12.1. INTRODUCTION
  7.12.2. LUMEDX CORPORATION PRODUCT PORTFOLIO
  7.12.3. LUMEDX CORPORATION RECENT ACTIVITIES
7.13. MCKESSON CORPORATION
  7.13.1. INTRODUCTION
  7.13.2. MCKESSON CORPORATION PRODUCT PORTFOLIO
  7.13.3. MCKESSON CORPORATION RECENT ACTIVITIES
7.14. MEDSTREAMING
  7.14.1. INTRODUCTION
  7.14.2. MEDSTREAMING PRODUCT PORTFOLIO
  7.14.3. MEDSTREAMING RECENT ACTIVITIES
7.15. MERGE HEATHCARE, INC.
  7.15.1. INTRODUCTION
  7.15.2. MERGE HEATHCARE,INC. PRODUCT PORTFOLIO
  7.15.3. MERGE HEATHCARE,INC. RECENT ACTIVITIES
7.16. PERMINOVA, INC.
  7.16.1. INTRODUCTION
  7.16.2. PERMINOVA,INC. PRODUCT PORTFOLIO
  7.16.3. PERMINOVA,INC. RECENT ACTIVITIES
7.17. PHILIPS HEALTHCARE
  7.17.1. INTRODUCTION
  7.17.2. PHILIPS HEALTHCAREPRODUCT PORTFOLIO
  7.17.3. PHILIPS HEALTHCARE RECENT ACTIVITIES
7.18. SIEMENS HEALTHCARE GMBH
  7.18.1. INTRODUCTION
  7.18.2. SIEMENS HEALTHCARE GMBH PRODUCT PORTFOLIO
  7.18.3. SIEMENS HEALTHCARE GMBH RECENT ACTIVITIES
7.19. ST. JUDE MEDICAL
  7.19.1. INTRODUCTION
  7.19.2. ST. JUDE MEDICAL PRODUCT PORTFOLIO
  7.19.3. ST. JUDE MEDICAL RECENT ACTIVITIES
7.20. TERUMO CARDIOVASCULAR GROUP
  7.20.1. INTRODUCTION
  7.20.2. TERUMO CARDIOVASCULAR GROUP PRODUCT PORTFOLIO
  7.20.3. TERUMO CARDIOVASCULAR GROUP RECENT ACTIVITIES

LIST OF TABLES

Table 1 GLOBAL CARDIOVASCULAR INFORMATION SYSTEM MARKET RESEARCH AND ANALYSIS BY TYPE, 2015-2022 ($ MILLION)
Table 2 GLOBAL CARDIOVASCULAR INFORMATION SYSTEMS MARKET RESEARCH AND ANALYSIS 2015-2022 ($ MILLION)
Table 3 GLOBAL CARDIOVASCULAR PICTURE ARCHIVE AND COMMUNICATIONS SYSTEM MARKET RESEARCH AND ANALYSIS 2015-2022 ($ MILLION)
Table 4 GLOBAL CARDIOVASCULAR INFORMATION SYSTEM MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2015-2022 ($ MILLION)
Table 5 GLOBAL HEART FAILURE CENTRE EVIS SOLUTIONS MARKET RESEARCH AND ANALYSIS 2015-2022 ($ MILLION)
Table 6 GLOBAL ECG AND HOLTER MONITORING EVIS SOLUTIONS MARKET RESEARCH AND ANALYSIS 2015-2022 ($ MILLION)
Table 7 GLOBAL CATHETERIZATION EVIS SOLUTIONS MARKET RESEARCH AND ANALYSIS 2015-2022 ($ MILLION)
Table 8 GLOBAL NUCLEAR CARDIOLOGY EVIS SOLUTIONS MARKET RESEARCH AND ANALYSIS 2015-2022 ($ MILLION)
Table 9 GLOBAL ELECTROPHYSIOLOGY EVIS SOLUTIONS MARKET RESEARCH AND ANALYSIS 2015-2022 ($ MILLION)
Table 10 GLOBAL CARDIOTHORACIC EVIS SOLUTIONS MARKET RESEARCH AND ANALYSIS 2015-2022 ($ MILLION)
Table 11 GLOBAL ECHOCARDIOGRAPHY LAB EVIS SOLUTIONS MARKET RESEARCH AND ANALYSIS 2015-2022 ($ MILLION)
Table 12 GLOBAL CARDIOVASCULAR INFORMATION SYSTEM MARKET RESEARCH AND ANALYSIS BY DEPLOYMENT, 2015-2022 ($ MILLION)
Table 13 GLOBAL ON-SITE BASED MARKET RESEARCH AND ANALYSIS 2015-2022 ($ MILLION)
Table 14 GLOBAL CLOUD OR WEBSITE BASED MARKET RESEARCH AND ANALYSIS 2015-2022 ($ MILLION)
Table 15 AGFA HEALTHCARE N.V PRODUCT PORTFOLIO
Table 16 AGFA HEALTHCARE N.V RECENT ACTIVITIES
Table 17 ARCPORTPRODUCT PORTFOLIO
Table 18 ARCPORTRECENT ACTIVITIES
Table 19 CAMTRONICS MEDICAL SYSTEMS LTD. PRODUCT PORTFOLIO
Table 20 CAMTRONICS MEDICAL SYSTEMS LTD. RECENT ACTIVITIES
Table 21 CERNER CORPORATION. PRODUCT PORTFOLIO
Table 22 CERNER CORPORATION. RECENT ACTIVITIES
Table 23 DIGISONICS,INC. PRODUCT PORTFOLIO
Table 24 DIGISONICS,INC. RECENT ACTIVITIES
Table 25 EBIT AET PRODUCT PORTFOLIO
Table 26 EBIT AET BIOSYSTEMS RECENT ACTIVITIES
Table 27 EPIC SYSTEMS CORPORATION PRODUCT PORTFOLIO
Table 28 EPIC SYSTEMS CORPORATION RECENT ACTIVITIES
Table 29 FUJIFILM MEDICAL SYSTEMS, INC. PRODUCT PORTFOLIO
Table 30 FUJIFILM MEDICAL SYSTEMS, INC. RECENT ACTIVITIES
Table 31 GE HEALTHCARE PRODUCT PORTFOLIO
Table 32 GE HEALTHCARE RECENT ACTIVITIES
Table 33 INFINITT NORTH AMERICA INC. PRODUCT PORTFOLIO
Table 34 INFINITT NORTH AMERICA INC. RECENT ACTIVITIES
Table 35 JOHNSON & JOHNSON PRODUCT PORTFOLIO
Table 36 JOHNSON & JOHNSON RECENT ACTIVITIES
Table 37 LUMEDX CORPORATION PRODUCT PORTFOLIO
Table 38 LUMEDX CORPORATION RECENT ACTIVITIES
Table 39 MCKESSON CORPORATION PRODUCT PORTFOLIO
Table 40 MCKESSON CORPORATION RECENT ACTIVITIES
Table 41 MEDSTREAMING PRODUCT PORTFOLIO
Table 42 MEDSTREAMING RECENT ACTIVITIES
Table 43 MERGE HEATHCARE,INC. PRODUCT PORTFOLIO
Table 44 MERGE HEATHCARE,INC. RECENT ACTIVITIES
Table 45 PERMINOVA,INC. PRODUCT PORTFOLIO
Table 46 PERMINOVA,INC. RECENT ACTIVITIES
Table 47 PHILIPS HEALTHCAREPRODUCT PORTFOLIO
Table 48 PHILIPS HEALTHCARE RECENT ACTIVITIES
Table 49 SIEMENS HEALTHCARE GMBH PRODUCT PORTFOLIO
Table 50 SIEMENS HEALTHCARE GMBH RECENT ACTIVITIES
Table 51 ST. JUDE MEDICAL PRODUCT PORTFOLIO
Table 52 ST. JUDE MEDICAL RECENT ACTIVITIES
Table 53 TERUMO CARDIOVASCULAR GROUP PRODUCT PORTFOLIO
Table 54 TERUMO CARDIOVASCULAR GROUP RECENT ACTIVITIES

LIST OF FIGURES

Figure 1 NORTH AMERICA MARKET RESEARCH AND ANALYSIS, 2015-2022 ($ MILLION)
Figure 2 US MARKET RESEARCH AND ANALYSIS, 2015-2022($ MILLION)
Figure 3 CANADA MARKET RESEARCH AND ANALYSIS, 2015-2022($ MILLION)
Figure 4 EUROPEAN MARKET RESEARCH AND ANALYSIS, 2015-2022($ MILLION)
Figure 5 UK MARKET RESEARCH AND ANALYSIS, 2015-2022($ MILLION)
Figure 6 FRANCE MARKET RESEARCH AND ANALYSIS, 2015-2022($ MILLION)
Figure 7 GERMANY MARKET RESEARCH AND ANALYSIS, 2015-2022($ MILLION)
Figure 8 ITALY MARKET RESEARCH AND ANALYSIS, 2015-2022($ MILLION)
Figure 9 SPAIN MARKET RESEARCH AND ANALYSIS, 2015-2022($ MILLION)
Figure 10 ROE MARKET RESEARCH AND ANALYSIS, 2015-2022($ MILLION)
Figure 11 ASIA PACIFIC MARKET RESEARCH AND ANALYSIS, 2015-2022($ MILLION)
Figure 12 INDIA MARKET RESEARCH AND ANALYSIS, 2015-2022($ MILLION)
Figure 13 CHINA MARKET RESEARCH AND ANALYSIS, 2015-2022($ MILLION)
Figure 14 JAPAN MARKET RESEARCH AND ANALYSIS, 2015-2022($ MILLION)
Figure 15 ROPAC MARKET RESEARCH AND ANALYSIS, 2015-2022($ MILLION)
Figure 16 REST OF THE WORLD MARKET RESEARCH AND ANALYSIS, 2015-2022($ MILLION)


More Publications